Haleon's investment thesis centers on its ability to sustain margin expansion through cost discipline and pricing power, evidenced by gross margin improving to 66.0% in 2026Q2 from 61.4% in 2024Q4, and operating margin reaching 23.8%. However, revenue growth r...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue stabilized around $5.5B per quarter with 3.0% growth in 2026Q2, while gross margin expanded to 66.0% and operating margin to 23.8%, driving net margin to 13.6%.
Potential for revenue growth up to +5.0% and EPS growth of +8.0% if pricing power remains strong and cost cuts are realized ahead of schedule.
Majority of analysts rate Haleon as Buy or Strong Buy, with a consensus 12-month price target of $10, implying +11.7% upside, and a bull case target of $20.
Haleon's strong portfolio includes well-known brands like Sensodyne, Advil, and Centrum, which are leaders in oral health, vitamins, and pain relief.
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 30, 2026 | $0.28+3.6% vs $0.27 | $7.5B+1.2% vs $7.4B |
Q1 2026 Feb 25, 2026 | $0.26+3.4% vs $0.25 | $7.5B-0.8% vs $7.6B |
Q4 2025 Oct 30, 2025 | $0.14-42.8% vs $0.24 | $7.5B+171.9% vs $2.8B |
Q3 2025 Aug 7, 2025 | $0.08-67.3% vs $0.24 | $7.3B+162.4% vs $2.8B |
Consumer health company Haleon has achieved growing sales of products to counter side-effects of weight-loss drugs in the United States, the company said, capitalising on the rising popularity of GLP-1 medication.
Investors with an interest in Consumer Products - Discretionary stocks have likely encountered both Lifetime Brands (LCUT) and Haleon PLC Sponsored ADR (HLN). But which of these two stocks offers value investors a better bang for their buck right now?
Sensodyne toothpaste maker Haleon has quietly negotiated better spots on shelves at U.S. retailers including Walmart and Target , to gain more visibility at a at a time when mounting grocery bills are hitting shopper spending.
Haleon (NYSE: HLN - Get Free Report) and Procter and Gamble (NYSE: PG - Get Free Report) are both large-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation. Risk and Volatility Haleon has a
Benchmark HLN against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Haleon plc (HLN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $9.11 | $40.63B | 19.11 | -1.81% | 14.78% | 9.98% | 1.93% | |
| $17.67 | $33.93B | 23.25 | -2.14% | 10.76% | 15.58% | — | |
| $96.03 | $22.75B | 31.80 | 1.57% | 11.96% | 17.78% | — | |
| $147.45 | $343.35B | 22.27 | 3.26% | 18.44% | 29.7% | — | |
| $85.93 | $68.76B | 32.67 | 1.4% | 9.68% | 306.89% | — | |
| $45.92 | $2.18B | 11.74 | -4.31% | 15.57% | 9.22% | — |
Haleon plc (HLN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when HLN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Haleon plc (HLN) stock FAQ — growth, dividends, profitability & financials explained
Haleon plc (HLN) reported $22.18B in revenue for fiscal year 2025. This represents a 162% increase from $8.48B in 2019.
Haleon plc (HLN) saw revenue decline by 1.8% over the past year.
Yes, Haleon plc (HLN) is profitable, generating $3.15B in net income for fiscal year 2025 (14.8% net margin).
Yes, Haleon plc (HLN) pays a dividend with a yield of 1.93%. This makes it attractive for income-focused investors.
Haleon plc (HLN) has a return on equity (ROE) of 10.0%. This is below average, suggesting room for improvement.
Haleon plc (HLN) generated $3.08B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
